Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
April 26, 2014
Fishy food for thought
R Robert Schellenberg
Respirology (Carlton, Vic.)
|
October 18, 2018
A letter from 'O Canada'
Don D Sin, R Robert Schellenberg
Clinical Allergy and Immunology
|
October 2, 2001
Extracellular matrix
Clive R Roberts, David C Walker, R Robert Schellenberg
Annals of Emergency Medicine
|
December 3, 2014
In reply
Brian E Grunau, Frank X Scheuermeyer, R Robert Schellenberg
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
June 5, 2012
The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients
Paul K Keith, Martin Desrosiers, Tina Laister, et al.
Canadian Respiratory Journal
|
August 16, 2006
The role of omalizumab in the treatment of severe allergic asthma
Kenneth R Chapman, Andre Cartier, Jacques Hébert, et al.
Canadian Journal of Physiology and Pharmacology
|
November 15, 2002
Tissue elastance influences airway smooth muscle shortening: comparison of mechanical properties among different species
Anabelle M Opazo Saez, R Robert Schellenberg, Mara S Ludwig, et al.
Immunology
|
November 9, 2002
Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways
Xueyan Zheng, Aly Karsan, Vincent Duronio, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1999
Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release
D A Knight, C P Lydell, D Zhou, et al.
Canadian Respiratory Journal
|
June 27, 2009
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)
Paul K Keith, Caroline Koch, Michel Djandji, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
April 26, 2014
Fishy food for thought
R Robert Schellenberg
Respirology (Carlton, Vic.)
|
October 18, 2018
A letter from 'O Canada'
Don D Sin, R Robert Schellenberg
Clinical Allergy and Immunology
|
October 2, 2001
Extracellular matrix
Clive R Roberts, David C Walker, R Robert Schellenberg
Annals of Emergency Medicine
|
December 3, 2014
In reply
Brian E Grunau, Frank X Scheuermeyer, R Robert Schellenberg
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|
June 5, 2012
The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients
Paul K Keith, Martin Desrosiers, Tina Laister, et al.
Canadian Respiratory Journal
|
August 16, 2006
The role of omalizumab in the treatment of severe allergic asthma
Kenneth R Chapman, Andre Cartier, Jacques Hébert, et al.
Canadian Journal of Physiology and Pharmacology
|
November 15, 2002
Tissue elastance influences airway smooth muscle shortening: comparison of mechanical properties among different species
Anabelle M Opazo Saez, R Robert Schellenberg, Mara S Ludwig, et al.
Immunology
|
November 9, 2002
Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways
Xueyan Zheng, Aly Karsan, Vincent Duronio, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1999
Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release
D A Knight, C P Lydell, D Zhou, et al.
Canadian Respiratory Journal
|
June 27, 2009
Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)
Paul K Keith, Caroline Koch, Michel Djandji, et al.
Page
of 2